Xeris Biopharma (NASDAQ: XERS - Get Free Report) and Corcept Therapeutics (NASDAQ: CORT - Get Free R

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CO

Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 10 years by 20.4% on an

Piper Sandler analyst David Amsellem reiterates Corcept Therapeutics (NASDAQ:CORT) with a Overwei

Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and

Dow Jones index gained 300 points, Lam Research Corp rose 20.1% after reporting strong financial res

Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:COR

Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares

Corcept Therapeutics shares soared 21.95% after hours as strong quarterly results and raised guidanc

Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio

Corcept Therapeutics (NASDAQ:CORT) raises FY2026 sales outlook from $950.000 million-$1.050 billion

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.36 per share which beat the ana

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and

Top Wall Street analysts changed outlook on several top stocks. See all changes on analyst ratings p

Wolfe Research analyst Kalpit Patel downgrades Corcept Therapeutics (NASDAQ:CORT) from Peer Perfo

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery

New data from CATALYST and MOMENTUM trials presented at American Diabetes Association's (ADA) 86

On May 19, 2026, Corcept Therapeutics Incorporated (the "Company") learned that the United S

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and

Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upg

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.

Top analysts change outlook for top names. Citigroup, Tigress Fin, Piper Sandler, Morgan Stanley, HC

U.S. stocks rose, with the Dow Jones gaining 350 points on Wednesday. AAR Corp (NYSE: AIR) saw a 10.

US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics sur

U.S. stocks advanced Wednesday as oil prices fell on Iran diplomacy reports. Arm jumped 15%, while T

U.S. stocks fall to four-month lows as oil surges above $110, Treasury yields spike, and markets pri

Stocks slipped Thursday as Trump comments on Iran lifted oil prices, boosting energy shares while fi

Corcept Therapeutics shares plunged Thursday morning after a federal appeals court upheld a ruling t

https://www.cafc.uscourts.gov/opinions-orders/24-1346.OPINION.2-19-2026_2649652.pdf

Precious metals continued to dominate Wall Street headlines on Friday as silver surged through the $

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3